Corvus Pharmaceuticals, Inc. (CRVS)

NGM – Цена в реальном времени. Валюта: USD

15.02

+0.29 (1.97%)

Рынок открыт: Aug 12, 2026, 2:29 PM EDT

14.77

+0.04 (0.27%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

07.08.2026

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

07.08.2026

Corvus Pharmaceuticals Q2 Earnings Call Highlights

Corvus Pharmaceuticals NASDAQ: CRVS reported a wider second-quarter loss as it increased spending on clinical development of soquelitinib, its selective ITK inhibitor, while outlining expected milestones across programs in peripheral T-cell lymphoma, atopic dermatitis, hidradenitis suppurativa and asthma.

06.08.2026

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic dermatitis trials on track Soquelitinib's potential in atopic dermatitis and broader immunology and inflammation indications supported by Phase 1 clinical, immunologic and biomarker data presented at the Society for Investigative Dermatology (SID) annual meeting Cash, cash equivalents and marketable securities of $215.2 million at June 30, 2026, providing runway into 2Q28 Conference call and webcast today at 4:30 pm ET / 1:30 pm PT SOUTH SAN FRANCISCO, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the second quarter ended June 30, 2026.

Видео

No Data

There is no data to display

Пресс-релизы

06.08.2026

Corvus Pharmaceuticals, Inc. (CRVS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

Corvus Pharmaceuticals Q2 Earnings Call Highlights

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

Corvus Pharmaceuticals Q2 Earnings Call Highlights

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Search stocks

Corvus Pharmaceuticals, Inc. (CRVS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

Corvus Pharmaceuticals Q2 Earnings Call Highlights

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

Corvus Pharmaceuticals Q2 Earnings Call Highlights

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results